John L. Knopf

2015

In 2015, John L. Knopf earned a total compensation of $7.4M as Chief Executive Officer and President at Acceleron Pharma, a 905% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$319,608
Option Awards$3,796,384
Salary$532,680
Stock Awards$2,767,010
Other$5,000
Total$7,420,682

Knopf received $3.8M in option awards, accounting for 51% of the total pay in 2015.

Knopf also received $319.6K in non-equity incentive plan, $532.7K in salary, $2.8M in stock awards and $5K in other compensation.

Rankings

In 2015, John L. Knopf's compensation ranked 893rd out of 13,638 executives tracked by ExecPay. In other words, Knopf earned more than 93.5% of executives.

ClassificationRankingPercentile
All
893
out of 13,638
94th
Division
Manufacturing
305
out of 5,187
94th
Major group
Chemicals And Allied Products
112
out of 1,857
94th
Industry group
Drugs
86
out of 1,531
94th
Industry
Biological Products, Except Diagnostic Substances
13
out of 260
95th
Source: SEC filing on April 15, 2016.

Knopf's colleagues

We found four more compensation records of executives who worked with John L. Knopf at Acceleron Pharma in 2015.

2015

Steven Ertel

Acceleron Pharma

Chief Operating Officer

2015

Matthew Sherman

Acceleron Pharma

Chief Medical Officer

2015

Kevin McLaughlin

Acceleron Pharma

Chief Financial Officer

2015

John Quisel

Acceleron Pharma

General Counsel

In-depth

You may also like